FDA Looks Ahead to Withdrawal of Nonprescription Epinephrine In...

With two years remaining until ozone-depleting nonprescription epinephrine inhalers must come off the market, FDA is seeking an effective way to inform those who purchase the products that they need to find an alternative remedy for asthma symptoms.

[Lynn]

FDA is not making the money here, so here come more regulations and another inferior product!!!! If the FDA was really interested in the wellbeing of Asthmatics and their needs, they would find a way to keep the effective CFC inhalers and Epinephrine available!!!
Google, Save CFC inhalers-join us!!!!